News About: Pharm. Industry
Pfizer and Pharmacia agreed in US$60 billion stock deal
Another big deal was recently made available, one year after the M&A deal between Glaxo Wellcome and SmithKline Beecham.
The Wall Street Journal reported on July 15 that Pfizer Inc. has agreed to buy Pharmacia Corp...
Win-Win strategic alliances between domestic firms and foreign-invested firms eyed
Market observers says that the win-win strategic alliances between domestic firms and foreign-investment firms need to be further strengthened for co-marketing and/or co-development of new drugs to effectively minimiz...
Entertaining physicians for sales promotion to be restrictive.
According to yakup.com survey over the marketing promotional entertainment for physicians from June 29 to July 11, about 603 respondents (49.9%) out of the total inquiries through the website indicated that any entert...
2001 output of finished drugs up 9.6 percent
The domestic output of finished drugs last year exceeding a 7-trillion won level marked a growth rate of 9.6 percent, an increase of 16 percentage points over the previous year (minus 6.4 percent), meaning that ...
Subsequent reduction of insurance prices deteriorating domestic pharmaceutical business
Business observers say that the recent government drug-related polices designed to reduce the insurance-covered drugs have dragged the overall pharmaceutical business into a serious setback, following a series of insu...
Shinpoon Pharm and WHO to jointly develop anti-malarial drug
Shinpoong Pharm announced on July 9 that it will jointly develop a novel anti-malarial drug in a tablet form until 2004 with the World Health Organization (WHO).
To that end, Shinpoong Pharm is to receive a $11.92...
More R&D investment to foster the pharmaceutical industry as the pivotal industries
Kim Chung-soo, chairman of the Korea Pharmaceutical Manufacturers Association, said during his July 8 press interview that the government needs to promote the domestic pharmaceutical industry as one of the pivotal ind...
Leading five pharmaceutical firms accounts for 60 percent in R&D investment
The combined turnover of the domestic pharmaceutical firms closing their fiscal year at December, including 37 KOSDAQ-listed pharmaceutical firms in 2001, marked an average growth rate of 9.8 percent, to 3.17 trillion...
Medical loan for pharmacies and medical institutions.
The Kookmin Bank has launched selling a bank loan titled "B2B Medical Loan" in the commercial markets especially for pharmacies, general hospitals, hospitals and clinics, up to 50% of annual sales volume in maximum or...
Overseas advance of pharmaceutical firms and bioventure firms looming
Business sources say the overseas advance of the domestic pharmaceutical firms and bioventure firm, which has been actively pushed for the timely development of new drugs in the biotechnology sector, is running into d...
